From: Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience
T Stage
PSA (ng/ml)
Gleason score
(Very) low risk
T1–T2a
< 10
2–6
Intermediate risk
T2b-c
10–20
7
(Very) high risk
T3a-b
>20
8–10